SEATTLE, WA — (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced it has entered a collaboration agreement with Ionis Pharmaceuticals, Inc. for the discovery, development and commercialization of… Read More
This authorization is the first authorized treatment of a patient with MDMA outside of a clinical trial in Canadian history VANCOUVER, BC — (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc…. Read More
Completed enrollment in Phase 2 Clinical Trial; data readout expected during calendar 3Q 2023 120% quarter-over-quarter revenue growth in the commercial BayMedica subsidiary Published a peer-reviewed study showing the anti-inflammatory… Read More
Three poster presentations at ASGCT 2023 will highlight the development of Aspect’s bioprinted liver tissue platform VANCOUVER, BC — Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue… Read More
Phase 1 clinical trial dosing completed Phase 1b/2a clinical trial of NVG-291 in individuals with chronic and subacute spinal cord injuries expected to commence in Q3 2023 Cash and investments of $18.0 million as… Read More
